These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 2336751

  • 21. [Changes in the renin-angiotensin-aldosterone system in glomerulonephritis].
    Kotovoĭ IuO.
    Urol Nefrol (Mosk); 1989; (5):53-8. PubMed ID: 2688249
    [Abstract] [Full Text] [Related]

  • 22. A follow up study of adult nephrotic syndrome in Nigerians: outcome and predictors of endstage renal failure.
    Ojogwu LI, Ukoli FA.
    Afr J Med Med Sci; 1993 Jun; 22(2):43-50. PubMed ID: 7839896
    [Abstract] [Full Text] [Related]

  • 23. [Lipid peroxides in the plasma of patients with chronic glomerulonephritis of the nephrotic type].
    Nikiforova NV, Sokolovskaia IV, Gonchar NA.
    Ter Arkh; 1983 Jun; 55(6):39-41. PubMed ID: 6612619
    [No Abstract] [Full Text] [Related]

  • 24. Arterial hypertension in chronic glomerulonephritis. An analysis of 310 cases.
    Danielsen H, Kornerup HJ, Olsen S, Posborg V.
    Clin Nephrol; 1983 Jun; 19(6):284-7. PubMed ID: 6872365
    [Abstract] [Full Text] [Related]

  • 25. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis?
    Muso E, Yashiro M, Matsushima M, Yoshida H, Sawanishi K, Sasayama S.
    Nephrol Dial Transplant; 1994 Jun; 9(3):257-64. PubMed ID: 8052431
    [Abstract] [Full Text] [Related]

  • 26. [Hypotensive therapy and the level of blood lipids in patients with chronic nephritis associated with arterial hypertension].
    Neverov NI, Kozlova RI, Vinogradova IV, Galstian GM, Shatskaia OB.
    Ter Arkh; 1989 Jun; 61(6):123-6. PubMed ID: 2799697
    [Abstract] [Full Text] [Related]

  • 27. Kimura disease: a case report and review of the Chinese literature.
    Wang DY, Mao JH, Zhang Y, Gu WZ, Zhao SA, Chen YF, Liu AM.
    Nephron Clin Pract; 2009 Jun; 111(1):c55-61. PubMed ID: 19052471
    [Abstract] [Full Text] [Related]

  • 28. Studies on the turnover of triglyceride and esterified cholesterol in subjects with the nephrotic syndrome.
    McKenzie IF, Nestel PJ.
    J Clin Invest; 1968 Jul; 47(7):1685-95. PubMed ID: 5658595
    [Abstract] [Full Text] [Related]

  • 29. [Evaluation of factors influencing platelet aggregation in patients with chronic glomerulonephritis (CGN)].
    Zdrojewski Z, Raszeja-Specht A, Kustosz J, Skibowska A, Rutkowski B.
    Przegl Lek; 1996 Jul; 53(5):434-8. PubMed ID: 8754409
    [Abstract] [Full Text] [Related]

  • 30. Kidney biopsy in SLE. I. A clinical-morphologic evaluation.
    Gladman DD, Urowitz MB, Cole E, Ritchie S, Chang CH, Churg J.
    Q J Med; 1989 Dec; 73(272):1125-33. PubMed ID: 2616734
    [Abstract] [Full Text] [Related]

  • 31. Reversible acute renal failure in idiopathic nephrotic syndrome.
    Furuya R, Kumagai H, Ikegaya N, Kobayashi S, Kimura M, Hishida A, Kaneko E.
    Intern Med; 1993 Jan; 32(1):31-5. PubMed ID: 8495041
    [Abstract] [Full Text] [Related]

  • 32. [Irreversible renal failure following minimal change nephrosis].
    Gekle D, Wartha R, Romen W.
    Monatsschr Kinderheilkd; 1984 Sep; 132(9):680-2. PubMed ID: 6387454
    [Abstract] [Full Text] [Related]

  • 33. [Lipid peroxidation and the system of antioxidant protection in patients with chronic glomerulonephritis and normal kidney azoturic function].
    Riabov SI, Kulikova AI, Tugusheva FA, Zubina IM, Kozlov VV.
    Ter Arkh; 1995 Sep; 67(12):33-7. PubMed ID: 8820054
    [Abstract] [Full Text] [Related]

  • 34. Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels.
    Naumnik B, Borawski J, Chyczewski L, Pawlak K, Mysliwiec M.
    Nephrol Dial Transplant; 2006 Dec; 21(12):3450-7. PubMed ID: 16982632
    [Abstract] [Full Text] [Related]

  • 35. Lipid and lipoprotein abnormalities in renal disease.
    Segura R, Gotto AM.
    Perspect Nephrol Hypertens; 1976 Dec; 3():159-200. PubMed ID: 814531
    [No Abstract] [Full Text] [Related]

  • 36. [Lipid metabolic disorders in patients with glomerulonephritis in the presence of a herpetic infection].
    Dudar IO, Rotova SO, Rudenko AV, Nikulina HH, Kruhlykov VT.
    Lik Sprava; 2000 Dec; (1):41-4. PubMed ID: 10878974
    [Abstract] [Full Text] [Related]

  • 37. Nephrotic syndrome: etiology, diagnosis, and treatment.
    Finkelstein FO, Hayslett JP.
    Geriatrics; 1976 Aug; 31(8):39-44, 48. PubMed ID: 780198
    [No Abstract] [Full Text] [Related]

  • 38. [Tubular lesions in the nephrotic syndrome].
    Robeva R, Lagrue J.
    Vutr Boles; 1989 Aug; 28(6):43-8. PubMed ID: 2576694
    [Abstract] [Full Text] [Related]

  • 39. Alcohol intake, cigarette smoking and plasma lipids and lipoproteins in 12--19-year-old children. The Collaborative Lipid Research Clinics Prevalence Study.
    Glueck CJ, Heiss G, Morrison JA, Khoury P, Moore M.
    Circulation; 1981 Sep; 64(3 Pt 2):III 48-56. PubMed ID: 7020984
    [Abstract] [Full Text] [Related]

  • 40. Disturbed lipids, lipoproteins and triglyceride-rich lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterol in post-renal transplant patients.
    Kimak E, Ksiazek A, Baranowicz-Gaszczyk I, Solski J.
    Ren Fail; 2007 Sep; 29(6):705-12. PubMed ID: 17763166
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.